Home Tags Forbes

Tag: Forbes

Michigan voters approve marijuana legalization

11/6/18--Voters in Michigan have opted to make their state the next to legalize marijuana. A ballot measure to replace marijuana prohibition with a legal and regulated system of cultivation and sales was approved by a margin of 56 percent to 44 percent. The measure will allow adults over 21 to possess, grow, and use small amounts of marijuana legally. Read

North Dakota marijuana legalization measure fails

11/6/18--North Dakota voters rejected a marijuana legalization ballot measure on Tuesday. The measure failed by a margin of 41 percent in favor to 59 percent against. The North Dakota initiative would have set no limit on the amount of marijuana that people could possess or cultivate. It would also have allowed a system of legal marijuana production and sales, but outlined no rules and regulations for the industry—something that would have been up to state lawmakers to tackle in the upcoming legislative session. Read

Missouri votes to legalize medical marijuana

11/6/18--Amendment 2, a constitutional amendment to allow medical marijuana, passed by a margin of 66 percent to 34 percent. Under the new law, qualified patients who have approval from their physicians will receive identification cards from the state that will allow them and their registered caregivers to grow up to six marijuana plants and purchase at least four ounces of marijuana from dispensaries on a monthly basis. Read

Utah voters approve medical marijuana

11/7/18--With nearly three-quarters of precincts reporting, Utah's medical marijuana ballot measure was leading by a margin of 53 percent to 47 percent, and NBC News and Salt Lake City's local Fox affiliate both projected that it was approved. Read

Why the adult cannabis market could kill its medical counterpart

9/11/18--As more states continue to legalize recreational marijuana, speculation among industry pundits is that this could be the precursor to a major slowdown, if not death knell, for the medical marijuana industry. According to estimates by leading cannabis researchers ArcView Market Research in partnership with BDS Analytics, the latest revenue projections for the U.S. medical marijuana industry in 2018 is $4.3 billion versus $6.7 billion for adult use. Last year, medical racked up $5.9 billion while adult use snagged $2.6 billion. Read

How medical marijuana is opening the door to recreational cannabis

9/12/18--Marijuana for medical use seems to be the path by which societies have been normalizing the use of marijuana. Forbes contributing writer Jordon Waldrep points out in his article that the legalization of marijuana for medical use and marijuana-derived drugs represents a significant change in thinking for the societies that have chosen to allow its consumption by patients. As patients see benefits and more research is done, the concerns on the potential for high abuse or severe safety concerns come into question as well, thus opening a path to recreational marijuana over time. Read

CBD company Charlotte’s Web debuts IPO

9/10/18--Colorado-based cannabidiol company, Charlotte’s Web completed its Initial Public Offering in Canada on August 30, 2018. The company’s shares trade on the Canadian Securities Exchange (“CSE”) under the ticker symbol “CWEB” and debuted at C$7.00 (US $5.40) per share. Read

These three cannabis stocks have been hijacked by traders

9/9/18--Three stocks, Canopy Growth, Cronos Group, and Tilray, have rallied sharply since August 14th. These three companies share a common trait in that they are all listed on the NASDAQ or the NYSE. This listing status has attracted traders in the U.S. who have avoided the sector. According to Cannabis industry analyst Alan Brockstein, traders have pushed these three stocks much higher than their peers that don't trade on a major U.S. exchange. Read

Can Article V federally legalize cannabis?

8/12/18--Article V, a legal precedent set by America’s founding fathers, permits two-thirds of the states to call for a Convention of States to put forth proposed amendments to the Constitution.  If the proposed amendment is passed by three-fourths of the states as they are comprised in Congress, then the Constitution will be amended. Article V has been considered to be the latest legal avenue to pursue to potentially challenge the current, federal administration’s predilection for prohibition. However, according to cannabis law expert, Bob Carp, pursuing an Article V legal strategy would be an exercise in futility. Apparently, Article V is not the best precedent for challenging federal prohibition. Read

FDA rejects petition to further restrict marijuana

7/5/18--The U.S. Food and Drug Administration (FDA) has denied a request from an anti-legalization group to place marijuana and its derivatives on a list of restricted substances that are not "generally recognized as safe and effective." The move is "not necessary for the protection of public health," Janet Woodcock, the director of FDA's Center for Drug Evaluation and research wrote on Monday in a letter to the group, Drug Watch International. Read

Sessions targets immigration protections as states consider sanctuary policies ror marijuana

3/8/18--U.S. Attorney General Jeff Sessions warned California that the federal government would use all its legal powers to fight protections provided unauthorized immigrants, a day after suing the state over its sanctuary laws. Read

Marijuana in casinos? Not until federal law changes, Vegas congresswoman says

11/2/17--Congresswoman Dina Titus voted for the marijuana legalization measure on Nevada’s ballot a year ago. Since then, she has been fighting on Capitol Hill to get the federal government to respect the decision she and a majority of her constituents made to end prohibition. Titus says she is hopeful that shifting poll results on legalization and the growing number of changing state laws will make Congress come around soon. Read

Scammers used my article and Montel’s name to hock ‘CBD’

10/29/17--A lawsuit is being filed on behalf of former TV host Montel Williams and Montel Williams Enterprises, Inc. over the misuse of his name and reputation in what is likely the first such case for the cannabis industry. Filed with the U.S. District Court in Miami, the complaint alleges that at least three companies linked to Timothy K. Isaac of Scottsdale, Arizona have intentionally and “blatantly” been using Williams’ reputation as a celebrity and CBD proponent following a Forbes article, as well as comments he made therein and elsewhere, to sell “purported CBD oils” through numerous websites as part of multiple “unscrupulous businesses online scams that are deceiving customers.” Read

Meet the CEO building a marijuana business news empire

10/16/17--Cassandra Farrington, CEO and co-founder of a brand new marijuana trade newsletter, Marijuana Business Daily, a.k.a., MJBiz Daily, and its mega trade conference, MJBiz Conference and Expo, which was named to Trade Show Executive’s “Fastest 50″ the last two years. With 843% overall growth across its verticals in 2016, MJBiz Daily won accolades as a top media company by Inc., landing on its Inc 5000 list. Farrington says she never dreamed she would be running a company, let alone one in the marijuana industry. Read

California officially calls on feds to reclassify marijuana

9/18/17--Last November, California voters approved a ballot measure to legalize marijuana. Now, the state’s lawmakers are formally calling on the federal government to reclassify cannabis. Researchers have long complained that marijuana’s classification creates additional hurdles that don’t exist for studies on other substances. Heroin and LSD are also in Schedule I alongside cannabis, yet cocaine and methamphetamine are classified in the less restrictive Schedule II category. Read

Justice Department no. 2 weighs in on marijuana legalization

9/14/17--According to Deputy Attorney General Rod Rosenstein, the Justice Department’s number two official, the Trump administration is continuing to weigh whether or not to reverse Obama-era guidance that generally allows states to legalize marijuana without federal interference. They are looking at the states that have legalized or decriminalized marijuana, trying to evaluate what the impact is. Without saying when a decision or announcement might be made, Rosenstein stated that the administration will take everything into consideration and then determine whether or not to revise that policy. Read

Study: Rise in marijuana use not caused by legalization

9/14/17--According to a study published in the online version of the journal Addiction, marijuana use is sharply rising in the United States, but the trend is not the result of the growing number of state laws that allow legal use of recreational or medical marijuana. Instead, the rise in cannabis use was “primarily explained by period effects,” meaning societal factors that affect populations across age and generational groups. The authors identify a decreasing disapproval of marijuana use as one such factor potentially at play they are clear that the rise in use was not caused by changes to marijuana laws. Read

Senators want Feds to make sure dispensary marijuana is safe

9/11/17--A powerful Senate panel is urging federal agencies to make a number of surprising marijuana moves, including launching an effort to test products sold at dispensaries in states where cannabis has been legalized. Concerned about a lack of data on the potency and purity of cannabis available to consumers, the U.S. Senate Appropriations Committee is directing federal agencies to formulate a “National Testing Program for Schedule I Marijuana-Derived Products.” Read

Hemp cannabis product sales projected to hit $1 billion in 3 years

8/23/17--Hemp-derived cannabidiol (CBD) is projected to be a billion-dollar market in just three years, according to a new report by Brightfield Group. The data company estimates that hemp CBD sales have already hit $170 million in 2016 and a 55% compound annual growth rate over the next five years will cause the market to crack the billion-dollar mark. Read

Marijuana legalization in Europe: Is France next?

1/6/17--Marijuana, a divisive issue that normally resurfaces in Europe during election campaigns, has come home to France’s hotly-contested presidential race. The political debate is less about interdiction or legalization, but, rather, about the nuances of what many are calling “an unavoidable course:” complete legalization or mere decriminalization. Read

States with medical marijuana laws have fewer traffic fatalities

12/31/16--States that passed medical marijuana laws have seen an 11% reduction in traffic fatalities on average, according to a new study published in the American Journal of Public Health. The most likely takeaway from this study is that medical marijuana laws are helping to decrease alcohol-related traffic fatalities among the age groups at highest risk, but other parts of this study don’t neatly line up behind any single conclusion. Read

Damian Marley invests in marijuana futures

screen-shot-2016-10-24-at-8-50-28-am10/11/16--Singer Damian Marley, who has opened a massive dispensary in Colorado at Mile High Stadium, is collaborating with Ocean Grown Extracts, and a part of their joint venture is to turn a vacant Coalinga, California prison into a medical marijuana manufacturing plant, which Ocean Grown will use to sell wholesale to dispensaries. Marley’s initial interest was born out of his fondness for Ocean Grown, but the scope and details of the venture came after the two started working together. Read

Five more states could legalize recreational marijuana on election day

screen-shot-2016-10-17-at-11-26-27-pm10/10/16--There are nine state ballot measures regarding the legalization of marijuana that will be voted on this November. Arizona, California, Maine, Massachusetts and Nevada are all looking to legalize recreational marijuana, while Arkansas, Florida, Montana and North Dakota are proposing medical marijuana legislation. Read

Retail marijuana could hurt medical marijuana

screen-shot-2016-10-10-at-8-12-41-pm9/28/16--A new report from GreenWave Advisors believes that legalized retail marijuana will disrupt the emerging medical sector. GreenWave wrote, “Though Arizona permits only medicinal use, new cardholder applications were down sharply in May, perhaps in anticipation of a favorable election outcome for recreational use.” Read

Cannabis attracting mainstream research analysts

screen-shot-2016-10-05-at-10-20-55-am9/22/16--Cowen and Company joins the ranks of the few mainstream research firms to officially begin covering the cannabis industry. A comprehensive 100 plus page report with contributions from ten different analysts was issued by Cowen Washington Research Group on September 12. Read

Can marijuana really reduce pot bellies and obesity?

screen-shot-2016-10-02-at-7-55-23-pm9/19/16--According to a recent study, marijuana users may be more likely to have a lower body mass index (BMI) or less likely to be obese or overweight than non-users. University of Miami researchers determined that women who use marijuana daily had on average BMIs approximately 3.1% lower than that of non-users. Read